We are live on ! Find out more
EC

EcoR1 Capital Portfolio holdings

AUM $2.34B
1-Year Est. Return 204.53%
This Fund
S&P 500
This Quarter Est. Return
+45.75%
1 Year Est. Return
+204.53%
3 Year Est. Return
+306.25%
5 Year Est. Return
+490.45%
10 Year Est. Return
+14,115.48%
AUM
$361M
AUM Growth
+$58M
Cap. Flow
-$53.8M
Cap. Flow %
-14.89%
Top 10 Hldgs %
83.89%
Holding
44
New
13
Increased
6
Reduced
5
Closed
11

Top Buys

1
CASC
Cascadian Therapeutics, Inc.
CASC
+$12.6M
2
CTMX icon
CytomX Therapeutics
CTMX
+$10.5M
3
FATE icon
Fate Therapeutics
FATE
+$9.28M
4
ACRS icon
Aclaris Therapeutics
ACRS
+$7.47M
5
TPST icon
Tempest Therapeutics
TPST
+$5.59M

Top Sells

1
ALXN
Alexion Pharmaceuticals
ALXN
+$19.8M
2
ARDX icon
Ardelyx
ARDX
+$18.6M
3
KYNB
Kyntra Bio
KYNB
+$15.7M
4
FPRX
Five Prime Therapeutics, Inc.
FPRX
+$15M
5
EDIT icon
Editas Medicine
EDIT
+$10.2M

Sector Composition

1 Healthcare 92.37%
2 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ASMB icon
1
Assembly Biosciences
ASMB
$529M
$75M 20.77%
245,264
– –
IRWD icon
2
Ironwood Pharmaceuticals
IRWD
$667M
$49.6M 13.72%
3,469,185
+59,700
+2% +$816K
LKFT
3
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.93B
$47.5M 13.15%
551,041
-10,300
-2% -$742K
ASND icon
4
Ascendis Pharma A/S
ASND
$17.4B
$28.7M 7.95%
1,025,700
+50,000
+5% +$1.26M
KURA icon
5
Kura Oncology
KURA
$1,000M
$23M 6.36%
2,611,906
– –
ACRS icon
6
Aclaris Therapeutics
ACRS
$775M
$20.1M 5.56%
673,100
+259,100
+63% +$7.47M
CTMX icon
7
CytomX Therapeutics
CTMX
$795M
$13.7M 3.8%
+794,969
New +$10.5M
CASC
8
DELISTED
Cascadian Therapeutics, Inc.
CASC
$12.4M 3.44%
+3,000,000
New +$12.6M
FATE icon
9
Fate Therapeutics
FATE
$336M
$11.5M 3.2%
+2,537,026
New +$9.28M
ATRA icon
10
Atara Biotherapeutics
ATRA
$76.9M
$8.94M 2.47%
17,392
+8,760
+101% +$3.63M
ATYR
11
aTyr Pharma
ATYR
$51.4M
$8.02M 2.22%
163,761
+93,976
+135% +$4.3M
TPST icon
12
Tempest Therapeutics
TPST
$16.8M
$6.57M 1.82%
+1,201
New +$5.59M
JNCE
13
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$5.68M 1.57%
+258,457
New +$5.48M
XNCR icon
14
Xencor
XNCR
$1.1B
$5.62M 1.56%
234,813
-140,187
-37% -$3.38M
KIN
15
DELISTED
Kindred Biosciences, Inc.
KIN
$3.84M 1.06%
544,880
-26,246
-5% -$164K
NBRV
16
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$3.18M 0.88%
1,059
– –
RGLS
17
DELISTED
Regulus Therapeutics
RGLS
$2.49M 0.69%
+12,583
New +$2.39M
ADVM
18
DELISTED
Adverum Biotechnologies
ADVM
$2.36M 0.65%
87,445
– –
ARAV
19
DELISTED
Aravive, Inc. Common Stock
ARAV
$2.13M 0.59%
+16,667
New +$1.76M
VIVE
20
DELISTED
VIVEVE MED INC
VIVE
$1.58M 0.44%
+250
New +$1.22M
AGIO icon
21
Agios Pharmaceuticals
AGIO
$2.37B
$1.36M 0.38%
23,300
– –
DRNA
22
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$1.3M 0.36%
+382,000
New +$1.08M
KYNB
23
Kyntra Bio
KYNB
$29.5M
$1.04M 0.29%
1,680
-25,767
-94% -$15.7M
SYRS
24
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$1.01M 0.28%
6,360
– –
BMY icon
25
Bristol-Myers Squibb
BMY
$119B
$928K 0.26%
17,060
+8,500
+99% +$466K
1
2

Similar funds

G
GenTrust Miami, Florida $2.34B AUM 18.43% 1-Year Est. Return
MC
Moors & Cabot Boston, Massachusetts $2.34B AUM 30.42% 1-Year Est. Return
BAM
Berkshire Asset Management Wilkes Barre, Pennsylvania $2.33B AUM 19.33% 1-Year Est. Return
CC
Capital Counsel New York $2.35B AUM 21.34% 1-Year Est. Return
HFM
Harvest Fund Management Beijing, China $2.35B AUM 49.85% 1-Year Est. Return
NO
Ninety One Cape Town, South Africa $2.33B AUM 92.42% 1-Year Est. Return
ST
Sageworth Trust Lancaster, Pennsylvania $2.33B AUM 20.04% 1-Year Est. Return
MFAM
Motley Fool Asset Management Alexandria, Virginia $2.33B AUM 21.93% 1-Year Est. Return